𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy

✍ Scribed by Mostafa K El Awady; Mohamed A Anany; Gamal Esmat; Naglaa Zayed; Ashraf A Tabll; Amr Helmy; Abdel Rahman El Zayady; Mohga S Abdalla; Hayat M Sharada; Maissa El Raziky; Wafaa El Akel; Shadia Abdalla; Noha G Bader El Din

Book ID
108953995
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
255 KB
Volume
26
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ribavirin pharmacokinetics and interleuk
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4
✍ Antonio D'Avolio; Alessia Ciancio; Marco Siccardi; Lorena Baietto; Marco Simiele 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

We read with great interest the recent report by Li et al. 1 analyzing the correlation between the clusters of differentiation 24 (CD24) polymorphism and risk of chronic hepatitis B virus (HBV) infection. In their study, the CD24 P170 T allele (thymidine at position 170) was correlated with a strong

Prevalence of hepatitis C virus genotype
Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin
✍ Kazuhiko Hayashi; Yoshiaki Katano; Teiji Kuzuya; Yoshihiko Tachi; Takashi Honda; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract Hepatitis C virus (HCV) genotype 1a is rare in Japanese patients and the clinical characteristics of this genotype remain unclear. The interferon (IFN) sensitivity‐determining region (ISDR) and single‐nucleotide polymorphisms (SNPs) of interleukin‐28B (IL28B) among patients with HCV gen